vs

Side-by-side financial comparison of Commercial Bancgroup, Inc. (CBK) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.

Commercial Bancgroup, Inc. is the larger business by last-quarter revenue ($23.1M vs $14.5M, roughly 1.6× SS Innovations International, Inc.). Commercial Bancgroup, Inc. runs the higher net margin — 41.3% vs -17.0%, a 58.3% gap on every dollar of revenue.

Commercial Bancgroup, Inc. operates as a U.S. regional bank holding company that provides a full suite of retail and commercial banking products and services to individual consumers, small and medium-sized businesses, and local institutional clients. Its core offerings include deposit accounts, lending solutions, wealth management, and tailored financial advisory services for regional markets.

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

CBK vs SSII — Head-to-Head

Bigger by revenue
CBK
CBK
1.6× larger
CBK
$23.1M
$14.5M
SSII
Higher net margin
CBK
CBK
58.3% more per $
CBK
41.3%
-17.0%
SSII

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBK
CBK
SSII
SSII
Revenue
$23.1M
$14.5M
Net Profit
$9.5M
$-2.5M
Gross Margin
43.9%
Operating Margin
-3.7%
Net Margin
41.3%
-17.0%
Revenue YoY
79.1%
Net Profit YoY
9.7%
-28.5%
EPS (diluted)
$0.69
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBK
CBK
SSII
SSII
Q1 26
$23.1M
Q4 25
$23.5M
$14.5M
Q3 25
$22.8M
$12.8M
Q2 25
$10.0M
Q1 25
$5.1M
Q4 24
$8.1M
Q3 24
$4.4M
Q2 24
$4.5M
Net Profit
CBK
CBK
SSII
SSII
Q1 26
$9.5M
Q4 25
$9.9M
$-2.5M
Q3 25
$9.5M
$-3.7M
Q2 25
$-256.7K
Q1 25
$-5.7M
Q4 24
$-1.9M
Q3 24
$-3.2M
Q2 24
$-4.1M
Gross Margin
CBK
CBK
SSII
SSII
Q1 26
Q4 25
43.9%
Q3 25
48.1%
Q2 25
59.1%
Q1 25
21.2%
Q4 24
48.9%
Q3 24
52.8%
Q2 24
31.9%
Operating Margin
CBK
CBK
SSII
SSII
Q1 26
Q4 25
-3.7%
Q3 25
53.8%
-14.3%
Q2 25
1.0%
Q1 25
-115.6%
Q4 24
-22.7%
Q3 24
-73.1%
Q2 24
-90.9%
Net Margin
CBK
CBK
SSII
SSII
Q1 26
41.3%
Q4 25
42.2%
-17.0%
Q3 25
41.4%
-29.0%
Q2 25
-2.6%
Q1 25
-111.0%
Q4 24
-23.7%
Q3 24
-74.0%
Q2 24
-91.8%
EPS (diluted)
CBK
CBK
SSII
SSII
Q1 26
$0.69
Q4 25
$0.72
$-0.01
Q3 25
$0.77
$-0.02
Q2 25
$0.00
Q1 25
$-0.03
Q4 24
$-0.01
Q3 24
$-0.02
Q2 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBK
CBK
SSII
SSII
Cash + ST InvestmentsLiquidity on hand
$3.2M
Total DebtLower is stronger
$118.2M
Stockholders' EquityBook value
$38.2M
Total Assets
$2.3B
$74.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBK
CBK
SSII
SSII
Q1 26
Q4 25
$3.2M
Q3 25
$154.8M
$5.7M
Q2 25
$11.4M
Q1 25
$15.9M
Q4 24
$466.5K
Q3 24
$220.4K
Q2 24
$608.2K
Total Debt
CBK
CBK
SSII
SSII
Q1 26
$118.2M
Q4 25
$166.8M
Q3 25
$100.1M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CBK
CBK
SSII
SSII
Q1 26
Q4 25
$38.2M
Q3 25
$245.2M
$39.6M
Q2 25
$42.0M
Q1 25
$40.6M
Q4 24
$13.5M
Q3 24
$13.7M
Q2 24
$14.8M
Total Assets
CBK
CBK
SSII
SSII
Q1 26
$2.3B
Q4 25
$2.3B
$74.2M
Q3 25
$2.2B
$69.6M
Q2 25
$70.0M
Q1 25
$63.5M
Q4 24
$42.4M
Q3 24
$39.0M
Q2 24
$35.7M
Debt / Equity
CBK
CBK
SSII
SSII
Q1 26
Q4 25
Q3 25
0.41×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBK
CBK
SSII
SSII
Operating Cash FlowLast quarter
$-1.5M
Free Cash FlowOCF − Capex
$-3.2M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBK
CBK
SSII
SSII
Q1 26
Q4 25
$-1.5M
Q3 25
$28.0M
$-7.5M
Q2 25
$-3.5M
Q1 25
$-6.1M
Q4 24
$-3.3M
Q3 24
$-2.5M
Q2 24
$-1.0M
Free Cash Flow
CBK
CBK
SSII
SSII
Q1 26
Q4 25
$-3.2M
Q3 25
$26.5M
$-8.2M
Q2 25
$-3.8M
Q1 25
$-7.0M
Q4 24
$-3.4M
Q3 24
$-4.2M
Q2 24
$-3.1M
FCF Margin
CBK
CBK
SSII
SSII
Q1 26
Q4 25
-22.3%
Q3 25
115.8%
-64.1%
Q2 25
-37.7%
Q1 25
-136.2%
Q4 24
-41.7%
Q3 24
-96.9%
Q2 24
-69.5%
Capex Intensity
CBK
CBK
SSII
SSII
Q1 26
Q4 25
11.8%
Q3 25
6.7%
5.9%
Q2 25
3.2%
Q1 25
17.0%
Q4 24
1.5%
Q3 24
38.8%
Q2 24
46.8%
Cash Conversion
CBK
CBK
SSII
SSII
Q1 26
Q4 25
Q3 25
2.96×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBK
CBK

Net Interest Income$20.5M89%
Noninterest Income$2.6M11%

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

Related Comparisons